Fresno, CA 29 October 2016 – Today at the UC Davis hosted, International Milk Genomics Conference, Dr. Kasper Hettinga, of Wageningen University in the Netherlands, presented a paper on titled Damage to potential allergy-preventing proteins by regular heating and UVC treatment, which featured results from research jointly conducted by Dr. Hettinga and Tamarack Biotics. Dr. Hettinga’s results demonstrated the ability of UVC to protect the immune active proteins, which are thought to be responsible for raw milk’s ability to prevent children from developing allergies.
Bob Comstock, Tamarack Biotics CEO stated, “the research conducted by The PASTURE Team including Erika von Mutius of University Hospital Munich, clearly demonstrated that raw milk consumption, as opposed to living on a farm, prevented children from developing allergies. We hope to extend this research into a commercial product that contains these same allergy-preventing compounds through our innovative non-thermal pathogen reduction and low-temperature drying technologies. Dr. Hettinga’s work proves the ability of UVC to protect these immune active proteins, which are thought to be responsible for raw milk’s allergy preventing ability”.
About Tamarack Biotics
Tamarack Biotics develops and produces dairy-based food ingredients that retain more of the immune active proteins and other thermally sensitive compounds than any other food ingredient. Tamarack Biotics utilizes non-thermal pathogen reduction and low-temperature drying technologies that fully dry milk and milk concentrates into stable powders at temperatures low enough to protect the thermally sensitive compounds, while achieving the same safety standards as traditionally pasteurized products.
This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are those other than historical statements of fact, and can be identified by words such as “believes,” “projects,” “anticipates,” “forecasts,” and the like. These statements are based on the Company’s estimates, beliefs and assumptions as of the date of this press release and are not a guarantee of any future performance. Forward-looking statements are subject to certain known risks and uncertainties, which are detailed in the Company’s periodic filings with the SEC available at www.sec.gov. Management undertakes no obligation to update information contained herein, which is subject to change without notice.